Tim O’Reilly
Impact in
Papers in
-
- Bacterial Infections and Vaccines 4
-
- Antibiotics Pharmacokinetics and Efficacy 6
- Co-authors
- Oto Zak (13 shared papers)Bernhard Moser (1 shared paper)Marcel Loetscher (1 shared paper)Roland D. Zwahlen (1 shared paper)Thomas Geiser (1 shared paper)Marco Baggiolini (1 shared paper)Marc Hattenberger (3 shared papers)Elisabeth Buchdunger (2 shared papers)
- Journals
- Journal of Medical Microbiology (3 papers)Journal of Antimicrobial Chemotherapy (3 papers)Infection and Immunity (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)
- Partner nations
- SwitzerlandUnited KingdomUnited States
In The Last Decade
Tim O’Reilly
27 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 108
- Virology 137
- Oncology 697
- Hematology 259
- Immunology 416
- Genetics 202
Countries citing papers authored by Tim O’Reilly
This map shows the geographic impact of Tim O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim O’Reilly more than expected).
Fields of papers citing papers by Tim O’Reilly
This network shows the impact of papers produced by Tim O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim O’Reilly. The network helps show where Tim O’Reilly may publish in the future.
Co-authors
The 25 scholars most cited alongside Tim O’Reilly, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | PTK787/ZK 222584, a novel and potent inhibitor of vascular endothelial growth factor receptor tyrosine kinases, impairs vascular endothelial growth factor-induced responses and tumor growth after oral administration. | 2000 | 738 |
| 2 | 1994 | 399 | |
| 3 | 2002 | 276 | |
| 4 | Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2-phenylaminopyrimidine class. | 2000 | 259 |
| 5 | PKC412--a protein kinase inhibitor with a broad therapeutic potential. | 2000 | 248 |
| 6 | 2001 | 85 | |
| 7 | 1991 | 57 | |
| 8 | 1992 | 50 | |
| 9 | 1997 | 50 | |
| 10 | 1992 | 39 | |
| 11 | 2000 | 35 | |
| 12 | 1990 | 26 | |
| 13 | 1990 | 19 | |
| 14 | 1993 | 19 | |
| 15 | 1999 | 18 | |
| 16 | 2003 | 11 | |
| 17 | 2001 | 11 | |
| 18 | 2001 | 11 | |
| 19 | 1995 | 8 | |
| 20 | 1992 | 8 |
About Tim O’Reilly
Tim O’Reilly is a scholar working on Microbiology, Pharmacology, Oncology, Molecular Medicine and Infectious Diseases, having authored 29 papers that have together received 2.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Orthopedic Infections and Treatments (4 papers), Bacterial Infections and Vaccines (4 papers), Cancer Treatment and Pharmacology (3 papers), PI3K/AKT/mTOR signaling in cancer (3 papers), Antibiotic Resistance in Bacteria (3 papers), Immune Response and Inflammation (3 papers) and HER2/EGFR in Cancer Research (2 papers). The work is most often cited by research in Virology (137 citations), Oncology (697 citations), Hematology (259 citations), Immunology (416 citations) and Genetics (202 citations). Tim O’Reilly has collaborated with scholars based in Switzerland, United Kingdom and United States. Frequent co-authors include Oto Zak, Bernhard Moser, Marcel Loetscher, Roland D. Zwahlen, Thomas Geiser, Marco Baggiolini, Marc Hattenberger, Elisabeth Buchdunger, Palma Iannarelli and Peter McL. Black. Their work appears in journals such as Journal of Medical Microbiology, Journal of Antimicrobial Chemotherapy, Infection and Immunity, Antimicrobial Agents and Chemotherapy and European Journal of Clinical Microbiology & Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.